High-throughput approaches for evaluating absorption, distribution, metabolism and excretion properties of lead compounds

被引:103
作者
Tarbit, MH
Berman, J
机构
[1] Glaxo Wellcome Res & Dev Ltd, Biomet Div, Int Sci Dev Grp, Ware SG12 0DP, Herts, England
[2] Glaxo Wellcome Inc, Div Chem, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1016/S1367-5931(98)80017-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Combinatorial chemistry methods and high-throughput screening for leads in industrial drug discovery have generated a potential bottleneck in the optimisation processes that seek to align potency with good pharmacokinetics in order to produce good medicines. This has resulted in the need for higher throughput methods of screening for absorption, distribution, metabolism and excretion properties. Significant progress has been made in throughput of in vivo pharmacokinetic studies, with the introduction of cassette, or multiple-in-one, protocols. In this technique, typically up to ten compounds are administered in one dose and analysed concomitantly on the mass spectrometer. High-throughput methods in in vitro absorption, distribution, metabolism and excretion are less well-developed as yet, and current approaches comprise automation of well-established methods for absorption using cell lines and metabolism using liver microsomes.
引用
收藏
页码:411 / 416
页数:6
相关论文
共 48 条
[1]   Caco-2 monolayers in experimental and theoretical predictions of drug transport [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :67-84
[2]   Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput [J].
Berman, J ;
Halm, K ;
Adkison, K ;
Shaffer, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :827-829
[3]  
BERMAN J, 1998, IN PRESS COMBINATORI
[4]   Pharmacokinetic screening for the selection of new drug discovery candidates is greatly enhanced through the use of liquid chromatography atmospheric pressure ionization tandem mass spectrometry [J].
Bryant, MS ;
Korfmacher, WA ;
Wang, SY ;
Nardo, C ;
Nomeir, AA ;
Lin, CC .
JOURNAL OF CHROMATOGRAPHY A, 1997, 777 (01) :61-66
[5]   Comparison of passive drug transport through Caco-2 cells and artificial membranes [J].
Camenisch, G ;
Folkers, G ;
vandeWaterbeemd, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 147 (01) :61-70
[6]  
Carlile DJ, 1997, DRUG METAB DISPOS, V25, P903
[7]   Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450 [J].
Crespi, CL ;
Miller, VP ;
Penman, BW .
ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :188-190
[8]  
Dando Sandra A., 1996, Pharmaceutical Research (New York), V13, pS240
[9]  
Delie F, 1997, CRIT REV THER DRUG, V14, P221
[10]  
FRICK LW, 1998, IN PRESS PHARM TECHN